Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients
Clinical trial NCT05649280 · COMPLETED
Trial details
- NCT number
- NCT05649280
- Sponsor
- Soutien aux Actions contre les Maladies du Globule Rouge
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.